Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

PLx Pharma Inc. (PLXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8700-0.1000 (-3.37%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 4.44
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 321.5000
52 Week Low 31.9250
50-Day Moving Average 33.3664
200-Day Moving Average 39.2648

Share Statistics

Avg Vol (3 month) 3245.44k
Avg Vol (10 day) 3266.43k
Shares Outstanding 527.54M
Implied Shares Outstanding 6N/A
Float 820.06M
% Held by Insiders 116.28%
% Held by Institutions 142.80%
Shares Short (Apr 28, 2022) 43M
Short Ratio (Apr 28, 2022) 417.73
Short % of Float (Apr 28, 2022) 411.11%
Short % of Shares Outstanding (Apr 28, 2022) 410.89%
Shares Short (prior month Mar 30, 2022) 43.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Apr 19, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-496.95%

Management Effectiveness

Return on Assets (ttm)-49.38%
Return on Equity (ttm)-141.80%

Income Statement

Revenue (ttm)8.21M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)3.4M
EBITDA -40.67M
Net Income Avi to Common (ttm)-48.65M
Diluted EPS (ttm)-3.1020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)69.39M
Total Cash Per Share (mrq)2.52
Total Debt (mrq)251k
Total Debt/Equity (mrq)0.48
Current Ratio (mrq)6.18
Book Value Per Share (mrq)1.12

Cash Flow Statement

Operating Cash Flow (ttm)-32.12M
Levered Free Cash Flow (ttm)-17.09M
Advertisement
Advertisement